Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2025.04.02
Z6尊龙:关于举行2024年度业绩说明会的通告
2025.03.28
Z6尊龙:年度关联方资金占用专项审计报告
2025.03.28
Z6尊龙:年度股东大会通知
2025.03.28
Z6尊龙:内部控制自我评价报告
2025.03.28
Z6尊龙:内部控制审计报告
2025.03.28
Z6尊龙:关于修订第二期员工持股妄想和第三期员工持股妄想的通告
2025.03.28
Z6尊龙:关于使用自有资金购置理工业品及举行现金治理的通告
2025.03.28
Z6尊龙:关于开展以套期保值为目的的外汇衍生品生意的可行性剖析报告
2025.03.28
Z6尊龙:关于会计师事务所2024年度履职情形评估报告
2025.03.28
Z6尊龙:关于公司2024年计提资产减值准备的通告
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】